PGxAI
Palo Alto
About PGxAI
Category-defining revenue generating AI-powered TechBio platform. PGxAI has built a proprietary first-in-class GenAI precision medicine model, leveraging trusted clinical guidelines and FDA/EMA recommendations, to predict individual responses to substances using multi-omics data.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Dec 2024)
- Website: pgx.ai
- Phone: 415-246-5322
Industries & Categories
Artificial Intelligence (AI), Biopharma, Life Science, Medical, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/pgxai-42433 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.